United Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
Amarin USD 67.47M 549K 2024-09
Ardelyx USD 108M 12M 2024-12
Baxter International USD 3.19B 644M 2024-12
Bayer EUR 11.41B 3.22B 2025-03
Biogen USD 2.12B 106.5M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Halozyme Therapeutics USD 123.33M 819K 2025-03
Insmed USD 340.96M 6.11M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
J&J USD 8.26B 10.37B 2025-03
Moderna USD 1.16B 1.06B 2025-03
Pfizer USD 10.05B 8.12B 2025-03
PTC Therapeutics USD 205.87M 69.79M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Teva Pharmaceutical Industries USD 3.37B 402M 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



United Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.